Archive for October, 2008

New HIV Drug Commercially Available

A new class of HIV drugs called integrase inhibitors aims to help control the virus among untreated patients is now available. Merck and Co. has just presented its drug Isentress (generic name raltegravir), the first drug on the market in this new class. Isentress is being sold as a twice-a-day pill. Researchers told during a meeting of the American Society of Microbiology and the Infectious Disease Society of America that they have discovered that Isentress works slightly better compared to a…

E-cards May Aid in STD Notification

Partner notification, or when a person is informed that one of his or her sexual partners was infected with sexually-transmitted disease, has been a cornerstone in controlling the spread of STDs like gonorrhea, chlamydia, and even HIV.  Traditionally, it has been done over the phone, by mail, or in person (together with the help of a public health worker). However, some cities have difficulty administering this exercise, as many STD-infected patients have had multiple sexual partners, making it …

HIV Vaccine Tests on Non-Human Primates Spark Debate

The immunodeficiency virus, or IV, only affects primates.  However, some species of primates have the ability to live with IV without progressing to AIDS-like illness like those experienced by rhesus macaques and humans.  This is the reason why researchers at this year’s international AIDS Vaccine Conference are debating whether or not should clinical trials for an AIDS vaccine be conducted on macaques.People who approve of the idea said that the simian immunodeficiency virus infection in macaqu…